A study to compare effect of patharphodi and sufoof-e-hajrul yahood in kidney stones

A single blind randomized parallel group clinical trial to compare the safety and efficacy of patharphodi (Didymocarpus pedicellata) with sufoof-e-hajrul Yahood in Hasa wa raml al-kulya (Nephrolithiasis) - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/074706

Enrollment

Registered

2024-10-03

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N202- Calculus of kidney with calculus of ureter

Interventions

Intervention1: Patharphodi (Didymocarpus pedicellata): 3 gms in powder form, twice a day for 45 days. Control Intervention1: Sufoof-e-Hajrul yahood: 5 gms, twice a day with water after meals for 45 da

Eligibility

Inclusion criteria

Inclusion criteria: 1.Calcium stone (oxalate and phosphate) 2.Calculi size less than 10mm 3.Non obstructive, single or multiple calculi

Exclusion criteria

Exclusion criteria: 1. Impaired renal functions 2. Obstructive single or multiple calculi 3. Calculi size more than 10 mm 4. Hydronephrosis 4. Pyelonephritis 5. Uncontrolled Diabetes mellitus and Uncontrolled Hypertension 6. Staghorn calculus 7. Renal failure 8. Pregnant and lactating women 9. Patient undergoing treatment for other serious illness

Design outcomes

Primary

Measure	Time frame
Reduction in symptoms and in size of calculusTimepoint: At 0th day, 15th day, 30th day and 45th day	—

Secondary

Measure	Time frame
Reduction in size of calculusTimepoint: Patient is assessed on 45th day	—

Countries

India

Contacts

Public ContactDr Ayesha siddiqua

Govt. Nizamia tibbi college and general hospital

ahmedfarhath66@gmail.com9848195067

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026